# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k083764   
B. Purpose for Submission: New Device   
C. Measurand: Amphetamine and methamphetamine   
D. Type of Test: Qualitative and semi-quantitative immunoassay   
E. Applicant: Roche Diagnostics Corporation   
F. Proprietary and Established Names: ONLINE Amphetamines II

# G. Regulatory Information:

1. Regulation section: 21 CFR $\$ 862.3100$ , Enzyme Immunoassay, Amphetamine 21 CFR § 862.3610, Methamphetamine test system   
2. Classification: Class II   
3. Product code: DKZ - enzyme immunoassay, amphetamine LAF - gas chromatography, methamphetamine

4. Panel: 91 (Toxicology)

# H. Intended Use:

1. Intended use(s): See Indications for use below.

2. Indication(s) for use:

Amphetamines II (AMPII) is an in vitro diagnostic test for the qualitative and semiquantitative detection of amphetamines and methamphetamines on automated clinical chemistry analyzers at cutoff concentrations of $3 0 0 ~ \mathrm { { n g / m L } }$ , $5 0 0 ~ \mathrm { { n g / m L } }$ and $1 0 0 0 ~ \mathrm { { n g / m L } }$ when calibrated with $d \mathbf { \cdot }$ -methamphetamine. Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Semiquantitative assays are intended to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as gas chromatography/mass spectrometry (GC/MS).

Amphetamines II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred

confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

# 3. Special conditions for use statement(s):

Amphetamines II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

For prescription use only

4. Special instrument requirements: Roche/Hitachi 917

# I. Device Description:

ONLINE Amphetamines II assay consists of ready for use reagent solutions. Reagent 1 (R1) contains conjugated drug derivatives in buffer with bovine serum albumin (BSA) and $0 . 0 9 \%$ sodium azide. Reagent 2 (R2) contains antibody/microparticle working solution with microparticles attached to anti-drug antibodies (mouse monoclonal) in buffer with bovine serum albumin (BSA) and $0 . 0 9 \%$ sodium azide.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Abuscreen ONLINE Amphetamines

2. Predicate 510(k) number(s): k983699

3. Comparison with predicate:

<table><tr><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">Amphetamines II Assay(k083764)</td><td colspan="1" rowspan="1">Predicate Device: AbuscreenONLINE Amphetamines(K983699)</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">KIMS, Kinetic interaction ofmicroparticles in solution</td><td colspan="1" rowspan="1">KIMS, Kinetic interaction ofmicroparticles in solution</td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Urine</td><td colspan="1" rowspan="1">Urine</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Qualitative and semi-quantitativedetection of amphetamines andmethamphetamines</td><td colspan="1" rowspan="1">Qualitative and semi-quantitativedetection of amphetamine andmethamphetamine</td></tr><tr><td rowspan="2">Reagents bovine serum albumin (BSA) and 0.09% sodium azide.</td><td rowspan="2">1. Conjugate Working Solution: Conjugated amphetamine and methamphetamine, in buffer with bovine serum albumin (BSA) and 0.09% sodium azide. 2. Antibody/Microparticle Working Solution: Microparticles attached to amphetamine, and methamphetamine, antibodies</td><td colspan="2">1. Antibody Working Solution: Amphetamine and methamphetamine monoclonal antibodies (mouse) in buffer with bovine serum albumin and preservative.</td></tr><tr><td>(mouse monoclonal) in buffer with and preservative.</td><td>2. Microparticle Working Solution: Conjugated amphetamine derivative microparticles in buffer</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI EP5-A2, Evaluation of Precision Performance of Quantitative Measurement Methods, Approved Guideline.

# L. Test Principle:

The ONLINE Amphetamines II assay is based on the kinetic interaction of microparticles in a solution (KIMS) as measured by changes in light transmission. In the absence of sample drug, soluble drug-polymer conjugates bind to antibody-bound microparticles, causing the formation of particle aggregates. As the aggregation reaction proceeds in the absence of sample, the absorbance increases. When a urine sample contains the drug in question, this drug competes with the conjugate-bound drug derivative for microparticle-bound antibody. Antibody bound to sample drug is no longer available to promote particle aggregation, and subsequent particle lattice formation is inhibited. The presence of sample drug diminishes the increasing absorbance in proportion to the concentration of drug in the sample. Sample drug content is determined relative to the value obtained for a known cutoff concentration of drug.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

The sponsor conducted two separate precision studies using Hitachi 917 analyzer for samples containing ${ \mathrm { d } }$ -methamphetamine and d-amphetamine. Precision was determined according to a CLSI (EP5-A2) precision protocol. Samples were prepared by spiking a negative human urine pool with either d-methamphetamine or d-amphetamine at the following concentrations: zero drug, $- 7 5 \%$ , $- 5 0 \%$ , and $- 2 5 \%$ below the cutoff, cutoff, and $+ 2 5 \%$ , $+ 5 0 \%$ , $+ 7 5 \%$ , and $+ 1 0 0 \%$ above the cutoff. The d-methamphetamine and ${ \mathrm { d } } .$ - amphetamine stock solutions had an analytically confirmed concentration of $1 \mathrm { m g / m L }$ based upon Certificate of Analysis. Samples were tested in 2 replicates per run, 2 runs per day for 21 days, total $\scriptstyle \mathrm { n = } 8 4$ . During precision testing with d-amphetamine, 9 calibrations were performed. During

precision testing with d-methamphetamine, 8 calibrations were performed. Results of the study are presented below:

# d-Amphetamine:

Qualitative - 300 ng/mL Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>262</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>334</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>75</td></tr><tr><td rowspan=1 colspan=1>378</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>438</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>484</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>555</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Semi-Quantitative - $3 0 0 ~ \mathrm { { n g / m L } }$ Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>262</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>83</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>334</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>79</td></tr><tr><td rowspan=1 colspan=1>378</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>438</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>484</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>555</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Qualitative - 500 ng/mL Cutoff   

<table><tr><td colspan="1" rowspan="2">SampleConcentrationng/mL</td><td colspan="1" rowspan="2">PercentCut-off(%)</td><td colspan="1" rowspan="2">#Observations</td><td colspan="2" rowspan="1">Results# Neg/ #Pos</td></tr><tr><td colspan="1" rowspan="1">#Negative</td><td colspan="1" rowspan="1">#Positives</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">143</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">268</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">392</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">527</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">76</td></tr><tr><td colspan="1" rowspan="1">656</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">723</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">934</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">1054</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr></table>

Semi-Quantitative - 500 ng/mL Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>143</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>268</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>392</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>527</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>82</td></tr><tr><td rowspan=1 colspan=1>656</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>723</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>934</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1054</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Qualitative - $1 0 0 0 ~ \mathrm { { n g / m L } }$ Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>554</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>755</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>1093</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>75</td></tr><tr><td rowspan=1 colspan=1>1384</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1629</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1877</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>2122</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Semi-Quantitative - 1000 ng/mL Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>554</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>755</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>1093</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>83</td></tr><tr><td rowspan=1 colspan=1>1384</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1629</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1877</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>2122</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

# d-methamphetamine:

Qualitative - 300 ng/mL Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>45</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>174</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>251</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>334</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>82</td></tr><tr><td rowspan=1 colspan=1>407</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>447</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>577</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>658</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Semi-Quantitative - 300 ng/mL Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>45</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>174</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>251</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>83</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>334</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>407</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>447</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>577</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>658</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Qualitative - $5 0 0 ~ \mathrm { { n g / m L } }$ Cutoff   

<table><tr><td colspan="1" rowspan="2">SampleConcentrationng/mL</td><td colspan="1" rowspan="2">PercentCut-off(%)</td><td colspan="1" rowspan="2">#Observations</td><td colspan="2" rowspan="1">Results# Neg/ #Pos</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positives</td></tr><tr><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">143</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">268</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">392</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">527</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">76</td></tr><tr><td colspan="1" rowspan="1">656</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">723</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">934</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">1054</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">#Negative</td><td colspan="1" rowspan="1">#Positives</td></tr><tr><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">143</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">268</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">392</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">527</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">71</td></tr><tr><td colspan="1" rowspan="1">656</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">723</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">934</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr><tr><td colspan="1" rowspan="1">1054</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">84</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">84</td></tr></table>

Qualitative - $1 0 0 0 ~ \mathrm { { n g / m L } }$ Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>61</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>554</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>755</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>1093</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>79</td></tr><tr><td rowspan=1 colspan=1>1384</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1629</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1877</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>2122</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

Semi-Quantitative - 1000 ng/mL Cutoff   

<table><tr><td rowspan=2 colspan=1>SampleConcentrationng/mL</td><td rowspan=2 colspan=1>PercentCut-off(%)</td><td rowspan=2 colspan=1>#Observations</td><td rowspan=1 colspan=2>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>#Negative</td><td rowspan=1 colspan=1>#Positives</td></tr><tr><td rowspan=1 colspan=1>61</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>554</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>755</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>1093</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>1384</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1629</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>1877</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr><tr><td rowspan=1 colspan=1>2122</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td></tr></table>

b. Linearity/assay reportable range:

Linearity across the range was confirmed by serially diluting a spiked urine pool containing drug in desired levels listed in the table below. Each sample was assayed on Hitachi 917 analyzer in the semi-quantitative mode. The results were averaged and compared to the expected result and the percent recovery was calculated. Sponsor calculated the $\%$ recovery by dividing the recovered result by the target concentration and then multiplying by 100. Results are presented below:

c. Traceability, Stability, Expected values (controls, calibrators, or methods):   

<table><tr><td rowspan=1 colspan=3>300 cutoff</td><td rowspan=1 colspan=3>500 cutoff</td><td rowspan=1 colspan=3>1000 cutoff</td></tr><tr><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>%Recovery</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>%Recovery</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>%Recovery</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>42.6</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>190.14</td><td rowspan=1 colspan=1>72</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>130.56</td><td rowspan=1 colspan=1>72.6</td><td rowspan=1 colspan=1>108</td><td rowspan=1 colspan=1>148.76</td></tr><tr><td rowspan=1 colspan=1>85.2</td><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>131.46</td><td rowspan=1 colspan=1>144</td><td rowspan=1 colspan=1>161</td><td rowspan=1 colspan=1>111.81</td><td rowspan=1 colspan=1>145.2</td><td rowspan=1 colspan=1>166</td><td rowspan=1 colspan=1>114.33</td></tr><tr><td rowspan=1 colspan=1>127.8</td><td rowspan=1 colspan=1>146</td><td rowspan=1 colspan=1>114.24</td><td rowspan=1 colspan=1>216</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>105.09</td><td rowspan=1 colspan=1>217.8</td><td rowspan=1 colspan=1>233</td><td rowspan=1 colspan=1>106.98</td></tr><tr><td rowspan=1 colspan=1>170.4</td><td rowspan=1 colspan=1>182</td><td rowspan=1 colspan=1>106.81</td><td rowspan=1 colspan=1>288</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>98.61</td><td rowspan=1 colspan=1>290.4</td><td rowspan=1 colspan=1>286</td><td rowspan=1 colspan=1>98.48</td></tr><tr><td rowspan=1 colspan=1>213</td><td rowspan=1 colspan=1>213</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>360</td><td rowspan=1 colspan=1>357</td><td rowspan=1 colspan=1>99.17</td><td rowspan=1 colspan=1>363</td><td rowspan=1 colspan=1>363</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>255.6</td><td rowspan=1 colspan=1>251</td><td rowspan=1 colspan=1>98.2</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>435</td><td rowspan=1 colspan=1>100.69</td><td rowspan=1 colspan=1>435.6</td><td rowspan=1 colspan=1>426</td><td rowspan=1 colspan=1>97.8</td></tr><tr><td rowspan=1 colspan=1>298.2</td><td rowspan=1 colspan=1>296</td><td rowspan=1 colspan=1>99.26</td><td rowspan=1 colspan=1>504</td><td rowspan=1 colspan=1>499</td><td rowspan=1 colspan=1>99.01</td><td rowspan=1 colspan=1>508.2</td><td rowspan=1 colspan=1>495</td><td rowspan=1 colspan=1>97.4</td></tr><tr><td rowspan=1 colspan=1>340.8</td><td rowspan=1 colspan=1>320</td><td rowspan=1 colspan=1>93.9</td><td rowspan=1 colspan=1>576</td><td rowspan=1 colspan=1>573</td><td rowspan=1 colspan=1>99.48</td><td rowspan=1 colspan=1>580.8</td><td rowspan=1 colspan=1>561</td><td rowspan=1 colspan=1>96.59</td></tr><tr><td rowspan=1 colspan=1>383.4</td><td rowspan=1 colspan=1>362</td><td rowspan=1 colspan=1>94.42</td><td rowspan=1 colspan=1>648</td><td rowspan=1 colspan=1>634</td><td rowspan=1 colspan=1>97.84</td><td rowspan=1 colspan=1>653.4</td><td rowspan=1 colspan=1>662</td><td rowspan=1 colspan=1>101.32</td></tr><tr><td rowspan=1 colspan=1>426</td><td rowspan=1 colspan=1>402</td><td rowspan=1 colspan=1>94.37</td><td rowspan=1 colspan=1>720</td><td rowspan=1 colspan=1>720</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>726</td><td rowspan=1 colspan=1>719</td><td rowspan=1 colspan=1>99.04</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>1240.5</td><td rowspan=1 colspan=1>1205</td><td rowspan=1 colspan=1>97.14</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>1860.75</td><td rowspan=1 colspan=1>1857</td><td rowspan=1 colspan=1>99.8</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>2481</td><td rowspan=1 colspan=1>2481</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3101.25</td><td rowspan=1 colspan=1>3046</td><td rowspan=1 colspan=1>98.22</td></tr></table>

The assay is calibrated using ${ \mathrm { d } } .$ -methamphetamine. Calibrators for cutoff levels (300 $\mathrm { n g / m L }$ , $5 0 0 ~ \mathrm { { n g / m L } }$ , $1 0 0 0 ~ \mathrm { { n g / m L } ) }$ included in this device has been previously cleared in k060645. Control materials for three cutoff levels have been previously cleared in k080183, k090939.

The sponsor provided the stability study protocols for reagent stability, and it is based on the real time stability studies conducted at $2 { - } 8 ^ { \circ } \mathrm { C }$ . The on-board stability for open vials is 56 days. The sponsor recommends that users should not freeze the reagents.

# d. Detection limit:

Performance at low drug concentrations in the semi-quantitative assay was characterized by determination of recovery (see section b above).

e. Analytical specificity:

Cross-reactivity was determined by spiking various concentrations of structurally similar drug compounds into drug-free urine. The cross reactivity studies were conducted for both semiquantitative and qualitative modes to determine the approximate quantity of each compound that is equivalent in assay reactivity to the 300, 500, and $1 0 0 0 ~ \mathrm { { n g / m L } }$ assay cutoff. The table below shows the semiquantitative results of the study for each assay cutoff. Similar results were generated for qualitative mode of the device.

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>ng/mLEquivalent to300 ng/mL</td><td rowspan=1 colspan=1>Approx.PercentCross-reactivity</td><td rowspan=1 colspan=1>ng/mLEquivalent to500 ng/mL</td><td rowspan=1 colspan=1>Approx.PercentCross-reactivity</td><td rowspan=1 colspan=1>ng/mLEquivalent to500 ng/mL</td><td rowspan=1 colspan=1>Approx.PercentCross-reactivity</td></tr><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>104</td><td rowspan=1 colspan=1>288</td><td rowspan=1 colspan=1>196</td><td rowspan=1 colspan=1>255</td><td rowspan=1 colspan=1>509</td><td rowspan=1 colspan=1>197</td></tr><tr><td rowspan=1 colspan=1>MDA</td><td rowspan=1 colspan=1>249</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>394</td><td rowspan=1 colspan=1>127</td><td rowspan=1 colspan=1>771</td><td rowspan=1 colspan=1>130</td></tr><tr><td rowspan=1 colspan=1>d-Amphetamine</td><td rowspan=1 colspan=1>251</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>494</td><td rowspan=1 colspan=1>101</td><td rowspan=1 colspan=1>981</td><td rowspan=1 colspan=1>102</td></tr><tr><td rowspan=1 colspan=1>MDEA</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>668</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>1553</td><td rowspan=1 colspan=1>64</td></tr><tr><td rowspan=1 colspan=1>d-Meth-amphetamine</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>488</td><td rowspan=1 colspan=1>102</td><td rowspan=1 colspan=1>998</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>MBDB HCI</td><td rowspan=1 colspan=1>323</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>598</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>1175</td><td rowspan=1 colspan=1>85</td></tr><tr><td rowspan=1 colspan=1>BDB HCI</td><td rowspan=1 colspan=1>717</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>1358</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>2420</td><td rowspan=1 colspan=1>41</td></tr><tr><td rowspan=1 colspan=1>l-Meth-amphetamine</td><td rowspan=1 colspan=1>2524</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>4383</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>8748</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>l-Amphetamine</td><td rowspan=1 colspan=1>7085</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>13342</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>24220</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Phendimetrazine</td><td rowspan=1 colspan=1>31818</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=1>65566</td><td rowspan=1 colspan=1>0.76</td><td rowspan=1 colspan=1>138504</td><td rowspan=1 colspan=1>0.72</td></tr><tr><td rowspan=1 colspan=1>Phentermine</td><td rowspan=1 colspan=1>70391</td><td rowspan=1 colspan=1>0.43</td><td rowspan=1 colspan=1>123457</td><td rowspan=1 colspan=1>0.41</td><td rowspan=1 colspan=1>238663</td><td rowspan=1 colspan=1>0.42</td></tr><tr><td rowspan=1 colspan=1>d-Pseudoephedrine</td><td rowspan=1 colspan=1>73822</td><td rowspan=1 colspan=1>0.41</td><td rowspan=1 colspan=1>112613</td><td rowspan=1 colspan=1>0.44</td><td rowspan=1 colspan=1>261780</td><td rowspan=1 colspan=1>0.38</td></tr><tr><td rowspan=1 colspan=1>Tyramine</td><td rowspan=1 colspan=1>85115</td><td rowspan=1 colspan=1>0.35</td><td rowspan=1 colspan=1>141643</td><td rowspan=1 colspan=1>0.35</td><td rowspan=1 colspan=1>284091</td><td rowspan=1 colspan=1>0.35</td></tr><tr><td rowspan=1 colspan=1>l-Ephedrine</td><td rowspan=1 colspan=1>89655</td><td rowspan=1 colspan=1>0.33</td><td rowspan=1 colspan=1>141643</td><td rowspan=1 colspan=1>0.35</td><td rowspan=1 colspan=1>308642</td><td rowspan=1 colspan=1>0.32</td></tr><tr><td rowspan=1 colspan=1>d,l-Phenyl-propanolamineHC1</td><td rowspan=1 colspan=1>211268</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>344828</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>606061</td><td rowspan=1 colspan=1>0.17</td></tr><tr><td rowspan=1 colspan=1>d-Ephedrine</td><td rowspan=1 colspan=1>215827</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>458716</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>657895</td><td rowspan=1 colspan=1>0.15</td></tr></table>

The cross-reactivity studies for structurally unrelated compounds were conducted using urine spiked with drug to low positive $( + 2 5 \% )$ concentration and a high negative $( - 2 5 \% )$ concentration for each cutoff level (300, 500, $1 0 0 0 ~ \mathrm { { n g / m L } ) }$ to determine the potential interference of the assay with variety of endogenous and pharmaceutical substances. Aliquots of pooled drug-free human urine and urine samples were further spiked with structurally unrelated compounds at a concentration of $1 0 0 0 0 0 \mathrm { n g / m L }$ (except for LSD [ $( 2 5 0 0 ~ \mathrm { n g / m L } ]$ and $\Delta$ -THC-9- carboxylic acid $[ 1 0 0 0 0 \mathrm { n g / m L } ] )$ . The results indicated that each compound listed below did not interfere with the accurate measurements of the device.

<table><tr><td>Acetaminophen Acetylsalicylic acid Amitriptyline</td><td>Diphenhydramine Diphenylhydanton Doxepin Ecgonine Erythromycin Furosemide Guaiacol glycerol ether Hydrochlorothiazide Ibuprofen Ketamine Levothyroxine LSD Meperidine</td></tr><tr><td>Ascorbic Acid</td><td>Naltrexone Naproxen</td></tr><tr><td>Aspartame</td><td>Ecgonine methyl ester Niacinamide</td></tr><tr><td>Benzocaine</td><td>Nicotine</td></tr><tr><td>Benzoylecgonine</td><td></td></tr><tr><td>Caffeine</td><td>Nifedipine</td></tr><tr><td>Cannabidiol</td><td>Nordiazepam</td></tr><tr><td>Cocaine</td><td>Omeprazole</td></tr><tr><td>Codeine</td><td>Oxazepam</td></tr><tr><td>Desipramine HCl</td><td>Penicillin G Phencyclidine</td></tr><tr><td>Dextromethorphan</td><td>Phenobarbital</td></tr><tr><td>Dextropropoxyphene</td><td>Quinine</td></tr><tr><td>Diazepam</td><td>Secobarbital</td></tr><tr><td>Digoxin</td><td></td></tr><tr><td>Methaqualone</td><td>Tetracycline</td></tr><tr><td></td><td>Δ^9-THC</td></tr></table>

Additionally, two separate studies were conducted for amphetamine and methamphetamine to evaluate the potential interference from substances found in urine. Both studies tested in semi-quantitative and qualitative modes. For both studies, the potentially interfering compound was spiked into human urine samples containing either d-amphetamine or ${ \mathrm { d } }$ -methamphetamine at concentrations roughly equivalent to the $\pm 2 5 \%$ cutoff concentration. The damphetamine and d-methamphetamine stock solutions had an analytically confirmed concentration of $1 \mathrm { m g / m L }$ based upon Certificate of Analysis. The results generated using a Roche/Hitachi 917 analyzer is listed below.

# d-Amphetamine:

<table><tr><td colspan="2" rowspan="1">Qualitative (ng/mL)</td><td colspan="2" rowspan="1">300 ng/mLCutoff</td><td colspan="2" rowspan="1">500 ng/mLCutoff</td><td colspan="2" rowspan="1">1000 ng/mLCutoff</td></tr><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">CompoundConcentration</td><td colspan="1" rowspan="1">NegLevel</td><td colspan="1" rowspan="1">PosLevel</td><td colspan="1" rowspan="1">NegLevel</td><td colspan="1" rowspan="1">PosLevel</td><td colspan="1" rowspan="1">NegLevel</td><td colspan="1" rowspan="1">PosLevel</td></tr><tr><td colspan="1" rowspan="1">Acetone</td><td colspan="1" rowspan="1">1 %</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">AscorbicAcid</td><td colspan="1" rowspan="1">1 %</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">ConjugatedBilirubin</td><td colspan="1" rowspan="1">0.1 mg/mL</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">2.75 mg/mL</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">Ethanol</td><td colspan="1" rowspan="1">1%</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="2" rowspan="1">Qualitative (ng/mL)</td><td colspan="2" rowspan="1">300 ng/mLCutoff</td><td colspan="2" rowspan="1">500 ng/mLCtoff</td><td colspan="2" rowspan="1">1000 ng/mLCutoff</td></tr><tr><td colspan="1" rowspan="1">Glucose</td><td colspan="1" rowspan="1">20 mg/mL</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">1 mg/mL</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">Humanserumalbumin</td><td colspan="1" rowspan="1">5 mg/mL</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">Oxalic Acid</td><td colspan="1" rowspan="1">2 mg/mL</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">SodiumChloride</td><td colspan="1" rowspan="1">0.25 M</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr><tr><td colspan="1" rowspan="1">Urea</td><td colspan="1" rowspan="1">5%</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td><td colspan="1" rowspan="1">NEG</td><td colspan="1" rowspan="1">POS</td></tr></table>

# d-Methamphetamine

<table><tr><td rowspan=1 colspan=2>Semiquantitative (ng/mL)</td><td rowspan=1 colspan=2>300 ng/mLCutoff</td><td rowspan=1 colspan=2>500 ng/mLCutoff</td><td rowspan=1 colspan=2>1000 ng/mLCutoff</td></tr><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>CompoundConcentration</td><td rowspan=1 colspan=1>NegLevel</td><td rowspan=1 colspan=1>PosLevel</td><td rowspan=1 colspan=1>NegLevel</td><td rowspan=1 colspan=1>PosLevel</td><td rowspan=1 colspan=1>NegLevel</td><td rowspan=1 colspan=1>PosLevel</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>1 %</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>1.5 %</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>ConjugatedBilirubin</td><td rowspan=1 colspan=1>0.1 mg/mL</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>5 mg/mL</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1 %</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>20 mg/mL</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>1 mg/mL</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Human serumalbumin</td><td rowspan=1 colspan=1>5 mg/mL</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>2 mg/mL</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>SodiumChloride</td><td rowspan=1 colspan=1>0.5 M</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>6 %</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td></tr></table>

There is the possibility that other substances and/or factors not listed above may interfere with the test and cause false results, e.g., technical or procedural errors.

The sponsor includes a note in the labeling about not assaying the Tina-quant Hemoglobin A1c Gen. 2 and the Amphetamines II assay on the same analyzer as follows:

“When you are running Amphetamines II, and Tina-quant Hemoglobin A1c Gen. 2 assay on a Hitachi 917 system, please avoid processing Amphetamines II as the first test from standby status. If no other testing is pending then a dummy test sample should be processed to prevent the Amphetamines II from being the first test from standby (Dummy test order any test having an R1 (not HbA1c).”

To test for possible positive and/or negative interference from specific gravity, the sponsor prepared samples containing drug at control levels $( \pm 2 5 \%$ of each cutoff concentration) with specific gravities ranging from 1.001 to 1.020. No positive or negative interference due to specific gravity was observed.

To test for potential negative interference from $\mathsf { p H }$ the sponsor prepared samples containing drug at control levels $( \pm 2 5 \%$ of each cutoff concentration) with pH ranging from 4.5 to 8.0. No negative interference due to pH was observed.

# f. Assay cut-off:

There are three cutoff concentrations claimed for both d-amphetamine and dmethamphetamine: $3 0 0 ~ \mathrm { { n g / m L } }$ ; $5 0 0 ~ \mathrm { { n g / m L } }$ ; $1 0 0 0 ~ \mathrm { { n g / m L } }$ .

2. Comparison studies:

a. Method comparison with predicate device:

The sponsor conducted an initial method comparison study to evaluate the performance of the device for d-methamphetamine. This study involved 190 unaltered clinical samples (114 negative and 76 positive) evaluated by the methamphetamine assay and also tested for methamphetamine using GC/MS. The agreement between GC/MS and new device results for both qualitative and semi-quantitative modes of the device are listed in the tables below.

Qualitative Assay Results:   

<table><tr><td colspan="1" rowspan="1">RocheONLINEDATAMPIIassay</td><td colspan="1" rowspan="1">Less thanhalf thecutoffconcentrationby GC/MSanalysis</td><td colspan="1" rowspan="1">Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td colspan="1" rowspan="1">Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td colspan="1" rowspan="1">High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td colspan="5" rowspan="1">300 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">69</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">108</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">500 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">69</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">110</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">1000 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">66</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">110</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td></tr></table>

Semi-Quantitative Assay Results:   

<table><tr><td rowspan=1 colspan=1>RocheONLINEDATAMPIIassay</td><td rowspan=1 colspan=1>Less thanhalf thecutoffconcentrationby GC/MSanalysis</td><td rowspan=1 colspan=1>Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td rowspan=1 colspan=1>Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td rowspan=1 colspan=1>High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td rowspan=1 colspan=5>300 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>69</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>109</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=5>500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>69</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=5>1000 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>66</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td></tr></table>

The sponsor evaluated the cause for the discrepant results generated between the new device and GC/MS for samples tested under qualitative and semi-quantitative modes. The results are listed in the table below.

<table><tr><td rowspan=1 colspan=1>CutoffValue(ng/mL)</td><td rowspan=1 colspan=1>Roche ONLINEDATMethamphetamineOBSERVEDResult</td><td rowspan=1 colspan=1>Roche ONLINEDATMethamphetamineEXPECTED Result</td><td rowspan=1 colspan=1>GC/MS(ng/mL)</td><td rowspan=1 colspan=1>Drug /Metabolite</td></tr><tr><td rowspan=1 colspan=1>300 (SQ&amp; Q</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>174</td><td rowspan=1 colspan=1>d-methamphetamine</td></tr><tr><td rowspan=1 colspan=1>300 (SQ&amp; Q</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>58710278</td><td rowspan=1 colspan=1>PseudoephedrineEphedrine</td></tr><tr><td rowspan=1 colspan=1>300 Q</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>76730124</td><td rowspan=1 colspan=1>PseudoephedrineEphedrine</td></tr><tr><td rowspan=1 colspan=1>500(SQ)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>181173</td><td rowspan=1 colspan=1>d-amphetamined-methamphetamine</td></tr><tr><td rowspan=1 colspan=1>1000(SQ &amp;Q</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>2834</td><td rowspan=1 colspan=1>d-amphetamine</td></tr></table>

The sponsor conducted two additional studies for both d-amphetamine and dmethamphetamine assays. The results were compared with GC/MS results for each cutoff concentration used in the new device. The sponsor used 40 unaltered urine samples negative for amphetamine or methamphetamine, including 4 near cutoff negative samples (i.e. values between cutoff and $- 5 0 \%$ of the cutoff by GC/MS for each drug), and 40 unaltered urine samples positive for amphetamine or methamphetamine including 4 near cutoff positive samples (i.e. values between cutoff and $+ 5 0 \%$ of the cutoff by GC/MS for each drug).

# New Device Results vs. stratified GC/MS Values for the d-Amphetamine assay:

The results for d-amphetamine listed in the tables below demonstrated a $9 2 . 5 \%$ negative agreement at the $3 0 0 ~ \mathrm { { n g / m L } }$ and $5 0 0 ~ \mathrm { { n g / m L } }$ cutoff concentrations with GC/MS for both the semiquantitative and qualitative assays. For d-amphetamine cutoff concentration of $1 0 0 0 ~ \mathrm { { n g / m L } }$ , the device produced $9 5 \%$ and $9 7 . 5 \%$ negative agreement with GC/MS results for semiquantitative and qualitative assays, respectively. $100 \%$ positive agreement was observed between GC/MS and the new device for both semiquantitative and qualitative assays at all cutoff levels. The comparison between GC/MS and new device results are listed in the tables below.

Qualitative Assay Results:   

<table><tr><td rowspan=1 colspan=1>RocheONLINEDATAMPIIassay</td><td rowspan=1 colspan=1>Less thanhalf thecutoffconcentrationby GC/MSanalysis</td><td rowspan=1 colspan=1>Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td rowspan=1 colspan=1>Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td rowspan=1 colspan=1>High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td rowspan=1 colspan=5>300 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=5>500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=5>1000 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Semi-quantitative Assay Results:   

<table><tr><td colspan="1" rowspan="1">RocheONLINEDATAMPIIassay</td><td colspan="1" rowspan="1">Less thanhalf thecutoffconcentrationby GC/MSanalysis</td><td colspan="1" rowspan="1">Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td colspan="1" rowspan="1">Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td colspan="1" rowspan="1">High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td colspan="5" rowspan="1">300 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">500 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">1000 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr></table>

The sponsor evaluated the cause for the discrepant results generated between the new device and GC/MS for negative samples, and determined that the samples contained dmethamphetamine that also produced a signal due to cross-reactivity. The results between GC/MS and new device cross reactivity data for d-amphetamine at $3 0 0 ~ \mathrm { { n g / m L } }$ cut-off are listed in the tables below.

<table><tr><td rowspan=1 colspan=1>Cutoff Value(ng/mL)</td><td rowspan=1 colspan=1>RocheONLINE DATAmphetaminesOBSERVEDResult</td><td rowspan=1 colspan=1>EXPECTEDResult ford-amphetamine</td><td rowspan=1 colspan=1>GC/MS(ng/mL)</td><td rowspan=1 colspan=1>Drug / Metabolite</td></tr><tr><td rowspan=1 colspan=1>300 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>157363</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>300 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>181173</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>300 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>220171</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>500 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>438121</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>500 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>4571152</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>500 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>443706</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>1000 (SQ)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>961</td><td rowspan=1 colspan=1>d-Amphetamine</td></tr><tr><td rowspan=1 colspan=1>1000 (SQ &amp; Q)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8371163</td><td rowspan=1 colspan=1>d-Amphetamined-Methamphetamine</td></tr></table>

¹ SQ – Semi-quantitative mode; Q – Qualitative mode

# New Device Results vs. stratified GC/MS Values for d-Methamphetamine:

The results for d-methamphetamine listed in the tables below indicated that for all cutoff concentrations, $90 \%$ negative agreement with GC/MS values for both the semiquantitative and qualitative assays was observed. $100 \%$ positive agreement was seen between GC/MS and the new device for both semiquantitative and qualitative assays at all cutoff levels. The agreement between GC/MS and new device results are listed in the tables below.

Qualitative Assay Results:   

<table><tr><td rowspan=1 colspan=1>RocheONLINEDATAMPIIassay</td><td rowspan=1 colspan=1>Less thanhalf thecutoffconcentrationby GC/MSanalysis</td><td rowspan=1 colspan=1>Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td rowspan=1 colspan=1>Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td rowspan=1 colspan=1>High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td rowspan=1 colspan=5>300 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=5>500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=5>1000 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Semi-quantitative Assay Results:   

<table><tr><td colspan="1" rowspan="1">RocheONLINEDATAMPIIassay</td><td colspan="1" rowspan="1">Less thanhalf thecutoffconcentrationby GC/MSanalysis</td><td colspan="1" rowspan="1">Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td colspan="1" rowspan="1">Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td colspan="1" rowspan="1">High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td colspan="5" rowspan="1">300 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">500 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">1000 ng/mL Cutoff</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr></table>

The sponsor evaluated the root cause for the discrepant results generated between the new device and GC/MS for negative samples, and determined that the samples contained d-amphetamine that also produced a signal due to the presence of antibody targeting damphetamine in the device. The results between GC/MS and new device cross reactivity data for d-methamphetamine at $3 0 0 ~ \mathrm { { n g / m L } }$ cut-off are listed in the tables below.

<table><tr><td colspan="1" rowspan="1">Cutoff Value(ng/mL)</td><td colspan="1" rowspan="1">RocheONLINE DATAmphetaminesⅡACTUALResult</td><td colspan="1" rowspan="1">EXPECTEDResult for d-methamphetamine</td><td colspan="1" rowspan="1">GC/MS(ng/mL)</td><td colspan="1" rowspan="1">Drug / Metabolite</td></tr><tr><td colspan="1" rowspan="1">300 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">173181</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">300 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">278101</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">300 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">220171</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">300 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">291145</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">500 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">488466</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">500 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">325171</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">500 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">291145</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">500 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">472650</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">1000 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">706443</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">1000 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">540693</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">1000 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">769395</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr><tr><td colspan="1" rowspan="1">1000 (SQ &amp; Q)</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">572432</td><td colspan="1" rowspan="1">d-Methamphetamined-Amphetamine</td></tr></table>

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable.   
b. Clinical specificity: Not Applicable.   
c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable.

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range: Not Applicable

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.